Exploring the Dynamics of Patent Licensing in Business Strategy

A patent gives its holder an exclusive right – but exclusivity alone does not generate revenue. A company might hold dozens or even hundreds of patents that it simply cannot commercialize through its own products or operations. This is where patent licensing becomes a critical business tool. By granting another party the right to use a patented invention in exchange for compensation, patent holders can unlock the economic value of their intellectual property without giving up ownership. For companies with large patent portfolios, licensing is often as important a revenue stream as the products they sell.

What patent licensing actually means 🔗

The word “license” traces back to the Latin term licentia, meaning freedom or liberty. In IP law, a patent license is a contractual permission granted by the patent owner (the licensor) to another party (the licensee) to make, use, or sell the patented invention under agreed terms. Crucially, the licensor retains ownership of the patent – only the right to use it is transferred, and only within the boundaries defined by the agreement. Under Section 68 of the Patents Act, 1970, every patent license agreement in India must be in writing to be legally valid. Furthermore, under Section 69 of the Act, registering the agreement with the Patent Office is essential for it to be admissible as evidence in any legal proceeding.

Types of patent licenses 🔗

Not all licensing arrangements work the same way. The structure of a license depends on how much exclusivity the licensor is willing to offer and what the licensee needs.

Exclusive license 🔗

In an exclusive license, all rights except the title of the patent are transferred to a single licensee for a defined period. The patent owner cannot grant the same rights to anyone else during this time – and in some cases, may even restrict its own use. This arrangement commands higher royalties precisely because the licensee gets a monopoly on using the technology.

Non-exclusive license 🔗

A non-exclusive license allows the patent owner to license the same patent to multiple parties simultaneously. This is common in industries where wide adoption of a technology – rather than market exclusivity – serves both the licensor’s revenue goals and the broader industry’s interest. The licensor earns from multiple streams while retaining the freedom to keep licensing.

Compulsory license 🔗

Not all licenses are negotiated voluntarily. A compulsory license is granted by the government – specifically, the Controller General of Patents – authorizing a third party to manufacture, use, or sell a patented invention without the patent owner’s consent. Under Section 84 of the Patents Act, 1970, an interested party may apply to the Controller for a compulsory license after three years from the date of patent grant, provided any of the following grounds are established: the reasonable requirements of the public are not being satisfied, the patented invention is not available at an affordable price, or the invention is not being worked within India’s territory.

India’s most landmark compulsory licensing case involved Natco Pharma and Bayer Corporation. In 2012, the Indian Patent Office granted Natco Pharma a compulsory license for Bayer’s cancer drug Sorafenib Tosylate (Nexavar), which was found to be inaccessible to the vast majority of patients due to its prohibitive cost of ₹2.8 lakh per month. The Controller set a royalty of 6% on net sales payable to Bayer and capped the price at ₹8,880 for a month’s treatment. This remains the only compulsory license granted in India post-TRIPS, and it reshaped how global pharmaceutical companies approach pricing and working of their patents in India.

Anatomy of a patent licensing agreement 🔗

A well-drafted licensing agreement is far more than a permission slip. It is a detailed commercial contract that allocates rights, risks, and rewards between the parties. The core terms of a licensing agreement typically cover the scope of use, territorial limits, duration, exclusivity, and financial compensation. Here is what each element means in practice:

• Scope of use: Precisely which rights are being granted – manufacturing, selling, sub-licensing, importing, or a combination. Ambiguity here is a common source of disputes.
• Territory: The geographic region within which the licensee can exercise the granted rights. A company may hold rights in India but be restricted from selling to markets in Southeast Asia.
• Duration: The term of the license, which cannot exceed the remaining life of the patent. Once a patent expires, it enters the public domain.
• Financial terms: This is the commercial heart of the agreement. Royalties can be structured as a fixed percentage of sales, a per-unit amount, or an upfront lump-sum fee – or a combination of all three.
• Sub-licensing rights: Whether the licensee can further license the technology to others. This is often restricted, especially in exclusive arrangements.
• Confidentiality and non-disclosure: Protection of proprietary technical information shared during and after the agreement.
• Dispute resolution: Arbitration clauses and governing law provisions, which are especially important in cross-border licensing.

How royalties are determined 🔗

Royalty calculation is one of the most negotiated aspects of any licensing deal. Traditionally, patent technology has been licensed using what is known as the 25% rule – where the profit from the patented technology is split in a 25:75 ratio between the licensor and the licensee respectively. However, this rule has increasingly been questioned and departed from in recent years, as courts and practitioners recognize that royalty rates must reflect the actual value contributed by the specific patent rather than an arbitrary formula. Factors such as the strength of the patent claims, market demand, the licensee’s profitability, and the scope of exclusivity all feed into negotiations. Broad patent claims – those that cover a wide range of variations of the technology – generally command higher royalties because they offer stronger protection against competitors working around the patent.

Voluntary licensing vs. direct sale: choosing the right route 🔗

In a direct patent sale, all rights including ownership are permanently transferred to a buyer for a one-time lump sum, while in licensing, all rights except ownership are temporarily transferred in exchange for royalties. Direct sales are typically preferred when a patent no longer supports a company’s core business and the maintenance costs outweigh the benefits of holding it. Licensing, on the other hand, is the preferred route when the patent was developed through academic-industry collaboration, or when business arrangements like joint ventures make it more strategic to retain ownership while enabling others to use the technology. Some companies even adopt a hybrid approach – licensing certain territories while selling rights in others.

Patent licensing as a business strategy 🔗

For companies with sizable patent portfolios, licensing is not an afterthought – it is a structured revenue strategy. Licensing can help companies start new ventures, expand into new markets, or strengthen their market reputation, all without the capital expenditure of physical expansion. From the licensee’s perspective, licensing provides access to proven, protected technology that can be built upon without the time and risk of independent R&D. This is particularly relevant in capital-intensive sectors like semiconductors, telecommunications, and pharmaceuticals.

In India’s growing startup and innovation ecosystem, licensing also plays a critical role in technology transfer – the process by which research outputs from universities and public institutions find their way into commercial products. When an IIT or CSIR laboratory develops a novel process and licenses it to a private company, that agreement defines not just the financial terms but also how the technology will be used, in what markets, and for how long. Without a well-structured licensing agreement, the innovation risks remaining confined to academic papers.

Due diligence before signing a license 🔗

Both parties should conduct thorough due diligence before entering a licensing agreement. Licensees especially should evaluate a patent carefully before committing – this includes reviewing any pending infringement or invalidation proceedings, the scope of the granted claims, and the market demand for the patented product. A patent with narrow claims may be easy for competitors to design around, significantly reducing the commercial value of the license. Licensors, for their part, should disclose any material information that could affect the licensee’s decision – not doing so can invite disputes or legal challenges down the line.

From a compliance standpoint in India, it is also important to check stamp duty implications under the Indian Stamp Act, 1899, since the rates vary by state. A license agreement that has not attracted adequate stamp duty cannot be admitted as evidence or acted upon in legal proceedings – a significant practical risk that is often overlooked during drafting.

Licensing and the broader IP ecosystem in India 🔗

India follows a first-to-file patent system. A foreign licensor can license an invention in India even before the patent is formally granted, though the agreement’s enforceability becomes clearer post-grant. India is a signatory to the Patent Cooperation Treaty (PCT) and the TRIPS Agreement, both of which shape the framework within which cross-border licensing operates. The National IPR Policy of 2016 has sought to improve coordination across government bodies to support stronger commercialization of patents, though challenges around enforcement and public access – particularly in pharmaceuticals – continue to define India’s position in the global IP conversation.

Whether a startup licensing its first patent to a larger player, or a multinational managing a portfolio of thousands of patents across jurisdictions, the fundamentals remain the same: the value of a patent is only realized when it is used, and licensing is one of the most efficient mechanisms to make that happen.

What do you think? As India pushes to become a global innovation hub, should compulsory licensing be more actively used to make critical technologies affordable – or does it risk discouraging companies from investing in R&D here? And from a business perspective, how should a startup founder decide between licensing out a patent versus building an entire product around it?

References

1. https://www.obhanandassociates.com/blog/intellectual-property-licensing-in-india/
2. https://www.legalserviceindia.com/legal/article-3477-patent-licensing.html
3. https://ssrana.in/articles/patent-licensing-strategies-effective-ip-commercialization/
4. https://www.iiprd.com/commentary-on-compulsory-licensing-under-the-patents-act-1970/
5. https://patentblog.kluweriplaw.com/2021/08/16/compulsory-license-india/
6. https://www.iiprd.com/grant-of-compulsory-license-in-india-its-provisions-and-need-in-several-industries-in-india/
7. https://www.oxyzo.in/blogs/intellectual-property-strategies-for-licensing-and-commercialization/112654
8. https://www.mondaq.com/india/patent/1513046/patent-licensing-strategies-for-effective-ip-commercialization
9. https://www.iiprd.com/ip-licensing-services/
10. https://www.lexology.com/library/detail.aspx?g=5ed6a7c9-a712-490d-8647-723a76722cf1